Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genes

Table 1 Disease entities enrolled and corresponding study groups

Disease entity	Abbreviation	Number of samples per disease entity	Study group	Number of samples per study group
Acute myeloid leukemia	AML	730	AML	730
Myelodysplastic neoplasm	MDS	713	MDS	713
Marginal zone lymphoma	MZL	71	MatureB group	375
Mantle cell lymphoma	MCL	71
High-grade B-cell lymphoma	HGBL	61
Lymphoplasmacytic lymphoma	LPL	59
Follicular lymphoma	FL	57
Other B-cell non-Hodgkin lymphomas	B-NHL	56
Myeloproliferative neoplasm	MPN	344	MPN	344
Chronic lymphocytic leukemia	CLL	279	CLL	279
Multiple myeloma	MM	236	PCN group	247
Monoclonal gammopathy of undetermined significance	MGUS	11	PCN group	247
Myelodysplastic/myeloproliferative neoplasm, unclassifiable	MDS/MPN-U	81	MDS/MPN group	207
Atypical chronic myeloid leukemia	aCML	67
Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis	MDS/MPN-RS-T	59
B-cell precursor acute lymphoblastic leukemia	BCP-ALL	204	BCP-ALL	204
T-cell non-Hodgkin lymphoma	T-NHL	90	T-cell group	174
T-cell acute lymphoblastic leukemia	T-ALL	84	T-cell group	174
Chronic myelomonocytic leukemia	CMML	142	CMML	142
Mastocytosis		98	Mastocytosis	98
Hairy cell leukemia	HCL	68	Hairy-cell group	97
Hairy cell leukemia variant	HCL-V	29	Hairy-cell group	97
Chronic myeloid leukemia	CML	92	CML	92
Chronic lymphoproliferative disorder of natural killer cells	CLPD-NK	58	NK	58

ISSN: 1756-994X